Top Markets
Coin of the day
Imagion Biosystems Limited Imagion Biosystems Limited

Imagion Biosystems Limited

IBX
Classement en actions #35262
Imagion Biosystems Limited operates as a medical imaging company that uses... Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to magnetic relaxometry. The company has collaboration agreement with Wayne State University to develop optimised MRI sequences which is in Phase 2 study of for the MagSense imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.
Prix de l'action
$0.00775813
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$4.19M
Changement (1 jour)
-15.38%
Changement (1 an)
-20.49%
Pays
AU
Échange Imagion Biosystems Limited (IBX)

Catégorie

Ratio P/B pour Imagion Biosystems Limited (IBX)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Imagion Biosystems Limited, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Imagion Biosystems Limited de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
4.1431 -
US
2.7156 -
US
- -
CN
24.3791 -
US
27.366 -
US